NCT01102465已完成不适用
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Bioequivalence determined by statistical comparison Cmax
研究概览
简要总结
The objective of this study was to prove the bioequivalence of losartan potassium/hydrochlorothiazide 100/25 mg tablet under fed conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to losartan potassium hydrochlorothiazide or any comparable or similar product.
结局指标
主要结局
Bioequivalence determined by statistical comparison Cmax
时间窗: 25 days
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted ConditionsHypertensionNCT01102478Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsHypertensionNCT01216852Roxane Laboratories40
已完成
不适用
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed ConditionsHypertensionNCT01216878Roxane Laboratories40
已完成
1 期
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)HypertensionNCT00953680Organon and Co77
已完成
1 期
A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting ConditionsHealthyNCT03459911Pharmtechnology LLC66